Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
3
×
boston
national top stories
startups
20/20 healthcare partners
abalos therapeutics
acetonid
achillion pharmaceuticals
aglios therapeutics
alexion pharmaceuticals
ally bridge group
amgen ventures
amy peterson
amyotrophic lateral sclerosis
anthony despasqua
aresenalbio
armo biosciences
asklepios biopharmaceutical
azitra
big data analytics
blackrock
boulder/denver blog main
boulder/denver top stories
bridgebio
cancer
cancer immunotherapy
casdin capital
checkmate pharmaceuticals
chemotherapy
christian angermayer
clinical trials
crispr
crispr therapeutics
cyteir therapeutics
cytomx therapeutics
dan brown
What
develop
3
×
new
3
×
bio
diseases
drugs
raised
analysis
associated
bails
biotech
brand
bridgebio
bring
capital
car
companies
company
device
dialysis
disease
drug
emerges
employing
enclear
firm
genetic
goldfinch
grab
harmful
headlines
ichnos
invest
ipo
kidney
later
lead
life
medicines
million
millions
Language
unset
Current search:
develop
×
new
×
" national blog main "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More